Introduction
Left ventricular ejection fraction (LVEF) is the most widely used performance index of LV systolic function, 1 although its predictive value for cardiac mortality is still questionable. 2 From an operational point of view, adequate cardiac function at rest is determined by the ability of the heart to fill at low pressure without causing congestion and to deliver a sufficient quantity of blood to revealed using conventional two-dimensional echocardiographic parameters, whereas the heart has multidimensional mechanical properties.
Speckle tracking imaging is used to study longitudinal, radial, and circumferential motion, thus providing insight into multidimensional myocardial mechanics. It is an accurate method to detect the myocardial deformation changes during ischaemia, dobutamine infusion, and increased afterload. 5 -8 Recently, we have shown that dobutamine-induced changes of LV global longitudinal strain (GLS) and strain rate (GLSR) were the best predictors of preserved functional capacity in patients with advanced heart failure with reduced ejection fraction (HFrEF). 9 However, little is known about the predictive value of dobutamine-induced changes of the multidimensional cardiac deformation indices for the long-term survival of these patients.
The aim of the present study was to investigate the predictive value of dobutamine-induced changes in longitudinal, circumferential, and radial strain and strain rate for the long-term survival of patients with severe HFrEF, during a 4-year follow-up period.
Methods

Study population
In this prospective, single-centre, cohort study we selected 130 patients who attended the Heart Failure Clinic between 2006 and 2009 and had the following eligibility criteria: (i) advanced heart failure according to European Society of Cardiology (ESC) guidelines; 10 (ii) NYHA classes III-IV; (iii) LVEF ≤35%; (iv) coronary angiography within the last year to define ischaemic vs. dilated cardiomyopathy; (v) on maximal tolerated medical treatment according to ESC guidelines 9 comprising beta-blockers, ACE inhibitors (or ARBs), diuretics, and mineralocorticoid receptor antagonists; and (vi) agreed to undergo low-dose dobutamine stress echocardiography (LDSE; 5, 10, and 20 μg/kg/min). Exclusion criteria were severe valvular heart disease, other severe co-morbidities, or presence of myocardial ischaemia requiring revascularization, as confirmed by high-dose dobutamine stress echocardiography (DSE; 5, 10, 20, 30, and 40 μg/kg/min) and/or thallium scintigraphy.
An LDSE study was performed at baseline in all patients. In ischaemic cardiomyopathy patients, LDSE was performed within 3 months of the initial assessment of ischaemia by high-dose DSE and/or thallium scintigraphy. LDSE was performed with patients under maximal tolerated treatment. Beta-blockers were withdrawn for 24 h before the LDSE. BNP levels were also measured.
Patients were followed as outpatients at 3-to 6-month intervals, starting from the day of the stress echocardiography study. Follow-up visits consisted of clinical assessment and standard 12-lead ECG. Of the 130 patients who initially underwent an LDSE, 100 completed a mean follow-up of 4 years (40 ± 10 months). Of the remaining 30, three suffered a non-cardiac death (car accident, and pancreatic and lung cancer, respectively) and the rest were lost to follow-up within 2 months of the LDSE and were excluded from the analysis. There were no statistically significant differences of the clinical characteristics between patients with and patients without follow-up (P > 0.05, data not shown). No patient underwent a heart transplant during follow-up.
The study protocol was approved by the local Ethics Committee, and all subjects provided written informed consent prior to their inclusion in the study. 
Primary outcome
The primary outcome was cardiac death (either in hospital or out of hospital) during the period of follow-up. Deaths of cardiac origin were defined as sudden cardiac death or death from cardiac pump failure as confirmed by death certificates and verified by medical record review and primary care physician interview. Non-cardiac death was not included in the analysis.
Standard echocardiography
Standard transthoracic echocardiographic measurements, including traditional indices of contractile reserve during LDSE [LVEF change and velocity-time integral of the LV outflow tract wave (LVOT-VTI) change], were carried out using a commercially available ultrasound device (Vivid 7, GE Medical Systems, Horten, Norway). 5 All measurements were carried out post-hoc by two experienced investigators (V.S. and I.I.) who were blinded to the patients' clinical data. Measurements were carried out by averaging five consecutive cardiac cycles.
The following parameters were measured: (i) LV end-diastolic diameter (LVEDD, mm) and end-systolic diameter (LVESD, mm), LV end-diastolic volume (LVEDV, mL) and end-systolic volume (LVESV, mL), and LVEF (%) using Simpson's method of discs, left atrial (LA) diameter (mm) and tricuspid annular plane systolic excursion (TAPSE, mm) by M-mode at the apical four-chamber view; (ii) LVOT-VTI (cm) in apical five-chamber view, peak E wave velocity (m/s) and deceleration time (DT, ms) of the mitral inflow waveform measured by pulsed wave Doppler and peak systolic velocity of tricuspid regurgitation by continuous wave Doppler to calculate systolic pulmonary artery pressure (sPAP, mmHg) in apical four-chamber view; and (iii) the mean value of systolic and early diastolic velocities (S' and E', m/s) from the septal, lateral, inferior, and anterior mitral annulus in the apical four-and two-chamber views using tissue Doppler imaging, and the ratio E/E'.
Speckle tracking imaging study
Left ventricular global longitudinal, circumferential, and radial strain and strain rate were measured from the standard two-dimensional acquisitions with the use of a dedicated software package (EchoPac, 110.05, GE Healthcare). Images were obtained at a frame rate of 50-80 frames/s. Global longitudinal strains were calculated using the 17 LV-segment model imaged from the apical four-, two-, and three-chamber views. The LV endocardial border was manually traced at the end-systolic frame, and the width of the region of interest was adjusted to accommodate the total thickness of the LV wall. Peak GLS (%) and strain rate (GLSR, L/s) were defined as the peak value on the strain and strain rate curves during the entire cycle, calculated from the entire U-shaped LV myocardium including the apical cap. Peak GLS was calculated from the average of the three apical views (apical four-, two-, and three-chamber view). Average circumferential (CS and CSR) and radial (RS and RSR) strain and strain rate were calculated from the six mid-LV segments (septal, anteroseptal, anterior, lateral, posterior, and inferior), of the parasternal short axis at the level of papillary muscles as previously reported. 8 Patients with more than three out of the 17 LV segments with poor image quality were rejected for the analysis. Thus, all patients finally included in the study had adequate images for speckle tracking imaging. In patients with AF, we measured the deformation markers in 10 cycles and the average value was used for analysis.
Dobutamine protocol
A stepwise low-dose dobutamine protocol was performed (5, 10, and 20 μg/kg/min) with a maximal dose of 20 μg/kg/min in order to increase cardiac inotropy without significant increases in heart rate and/or blood pressure (BP). Each step had a 10 min duration to achieve a haemodynamic steady state for at least 2 min at the end of it. During dobutamine infusion, BP and heart rate were recorded every minute and a 12-lead ECG was performed. The conventional echo measurements, as well as the deformation parameters were measured at rest and at the steady-state phase of the 20 μg/kg/min dobutamine dose. Dobutamine-induced change in all echocardiographic indices was defined as the difference between the value obtained at 20 μg/kg/min minus that at rest.
To exclude clinically significant myocardial ischaemia, the high dose dobutamine protocol was performed before inclusion in the study using a maximal dobutamine dose of 40 μg/kg/min plus atropine (when applicable) to achieve a BP and heart rate >85% of that predicted for age and sex to elicit myocardial ischaemia.
Intra-and interobserver variability and feasibilty
The intra-and interobserver variability for LV strain parameters were 8% and 9%, respectively, at rest and 7.5% and 10%, respectively, during peak dobutamine infusion. Based on image quality, some segments of the myocardium could not be visualized properly and thus echo studies were rejected from strain analysis. Thus, in our laboratory, longitudinal strain (LS) was assessed in all myocardial segments in 95% of the echo studies at rest and in 93% at LDSE, CS in 96% at rest and 94% at LDSE, and RS in 97% of the echo studies at rest and 94% at LDSE (feasibility of strain assessment >95% at rest and >94% at LDSE).
BNP measurement
Venous blood samples were collected at rest for the measurement of plasma BNP using the rapid Triage BNP assay (Biosite Inc., San Diego, CA, USA).
Statistical analysis
We assumed that patients with a value of GLS change post-DSE within the lowest tertile would have a shorter survival time than patients with GLS change values over the lowest tertile and that the hazard ratio (HR) of patients with GLS change values within the lowest tertile vs. those with GLS change values within the mid and upper tertile would be 2.8. Based on a previous study, 11 we assumed that the median survival of the patients with GLS change within the mid and upper tertile is 36 months. Our study was planned to have an accrual interval of 12 months and an additional mean follow-up after the accrual interval of 36 months. We estimated that we would need to study 32 patients with GLS change values at the lowest tertile and 64 patients with GLS change values over the lowest tertile (a total of 96 subjects) to be able to reject the null hypothesis that the survival curves of these two groups are equal with probability (power) 0.80. The Type I error probability associated with this test of this null hypothesis is 0.05 
Single variable comparisons
Cox regression
Cox proportional hazards models were created to assess the independent risk of each echocardiographic parameter for cardiac mortality. All echocardiographic variables at rest, and the variables representing the difference between values at rest and with dobutamine, were divided by their respective standard deviations (SDs) to give standardized values. The standardized variables were then input into the Cox models, such that the HRs correspond to one SD change of each variable. Univariate analysis consisted of simple Cox regression modelling, with each variable as the sole linear predictor. For multivariate regression, the basic model consisted of the main effects of eight traditional predictive factors, namely age, sex, cardiomyopathy aetiology (ischaemic vs. non-ischaemic), NYHA class, heart rhythm (sinus rhythm vs. AF), BNP levels, LVEF at rest, as well as a dobutamine-induced change of LVOT-VTI >20%, a validated cut-off value for the presence of contractile reserve. 12 Each further echocardiographic parameter was then added, one at a time, to the basic model to assess its respective adjusted risk for mortality. Pairwise model comparisons for statistical difference were performed using log-likelihood 2 test.
Harrell's C-index, as a measure of discrimination, was used for the assessment of the predictive value of each univariate and multivariate Cox model. 13 Moreover, we assessed the prediction improvement of all multivariate models against the basic model, based on the estimation of the category-free net reclassification index (NRI). 12 The estimations of Harrell's C and NRI were tested and improved with 1000-loop bootstrapping (corrected C-index). To test the additive value of echocardiography parameters, we added to the basic model the resting and/or the LDSE markers with the greatest C-index for the prediction of mortality. Thus, we constructed a parsimonious final model with no more than six independent predictors to avoid overfitting. The main effects of the predictors and the second-order interactions were exhaustively tested. Goodness of fit of the final model was assessed using graphical methods such as a log-minus-log plot and a cumulative residuals plot.
To assess the temporal trends of the predictive accuracy of the three survival models, we estimated the Heagerty cumulative time-dependend receiver operating characteristic (ROC), which assumes cases as those who died before time t and controls as those who survived until time t. In addition, we assessed the incidence-based time-dependent ROC, which assumes cases as those who died at time t (incident cases) and controls as those who survived until time t (dynamic controls). 14 Optimal cut-off values for echocardiographic measurements with an effect on long-term mortality were estimated from the respective ROC analysis of univariate Cox regression models. Then Kaplan-Meier curves conditional on these cut-off values were plotted and pairwise compared with the log-rank test.
The statistical analysis was conducted with SPSS v.20 (IBM Corp.) and R language v3.2.2 (R Foundation for Statistical Computing, Vienna, Austria).
Results
From the 100 patients of the study population, 32 died (14 from sudden death and 18 from pump failure) during a mean 57 ± 10 5 9 ± 10 2 ± 13 5 6 ± 8 5 9 ± 6 2 ± 11
All 100 patients had adequate echocardiography images for strain analysis of all myocardial segments. DBP, diastolic blood pressure; DT, deceleration time; GFR, glomerular filtration rate calculated by the Cockcroft-Gault formula; HR, heart rate; ICD, implantable cardioverter defibrillator; LA, left atrial; LVEDD, left ventricular end-diastolic diameter; LVEDV, left ventricular end-diastolic volume; LVESD, left ventricular end-systolic diameter; LVESV, left ventricular end-systolic volume; LVOT-VTI, left ventricular outflow track velocity-time integral; SBP, systolic blood pressure; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TDI, tissue Doppler imaging. * Paired comparisons within groups (survivors, patients with cardiac death) at rest vs. dobutamine: *P < 0.05; **P < 0.01; ***P < 0.001. † Comparisons between groups (survivors, patients with cardiac death) at rest: † P < 0.05; † † P < 0.01; † † † P < 0.001. ‡ Comparisons between groups (survivors, patients with cardiac death) with dobutamine: ‡ P < 0.05; ‡ ‡ P < 0.01; ‡ ‡ ‡ P < 0.001.
follow-up of 40 ± 10 months. Among those who died, the median time of cardiac death was 19.5 months and the interquartile range was 8.75 months. All 100 patients had adequate echocardiography images for strain analysis of all LV myocardial segments.
Rest echocardiography
Baseline characteristics of the study population are shown in Table 1 . Baseline mean LVEF was 30 ± 6% overall, and did not differ significantly between survivors and patients with cardiac death (P = 0.416; greater, while LA diameter, sPAP, and E/E' were lower in survivors than in non-survivors (P < 0.05, Table 1 ). Among deformation echocardiographic measurements, RS and RSR differed significantly between the two groups (P < 0.001; Table 1 ). A borderline difference (P = 0.044) was also shown for CS.
Dobutamine stress echocardiography
In the overall cohort, LVESD and LVESV were reduced during LDSE (P = 0.010 and P = 0.041, respectively). LVOT-VTI was increased (P < 0.001), while LVEF did not differ (P = 0.101). However, using previously reported cut-off values for LVEF and LVOT-VTI to define contractile reserve, 11 a dobutamine-induced change of LVEF >5% was observed only in 47 (47%) patients and a change of LVOT-VTI >20% in 60 (60%) patients. Conversely, all the deformation indices exhibited a significant change after dobutamine infusion. The same results concerning echo measurements also hold true for the group of survivors. In the group of patients with cardiac death, only LVOT-VTI, GLS, and GLSR exhibited a significant change during LDSE (P < 0.001). A borderline change was noted for CSR and RSR (P = 0.041 and P = 0.044, respectively). Among conventional echo measurements during LDSE, only LVOT-VTI showed a significant difference between survivors and patients with cardiac death ( Table 1 , P < 0.001). In contrast, all speckle tracking echo measurements during LDSE were significantly different between the two groups (P < 0.001), as shown in Table 1 . Furthermore, basal GLS and GLS change post-DSE were lower in patients who died suddenly (n = 14) compared with those who did not (−7.5 ± 0.5 v. -8.6 ± 2.1, P = 0.025 and −0.26 ± 1.2 vs. 1.88 ± 0.9, P < 0.01, respectively). Figure 1A shows the survival curve of the overall population. Among myocardial deformation markers at rest, a GLS less than −8% and RS less than 15.3% (cut-off values derived by ROC analysis) were the best predictors of increased cardiac mortality (log rank P < 0.01, Figure 1B and C). We also calculated the dobutamine-induced changes in strain measurements as percentages relative to their values at rest. The optimal cut-off value of GLS percentage change to predict survival was 19.0% as derived by ROC analysis. As shown in Figure 1D , the Kaplan-Meier survival curves according to this specific cut-off value are significantly different (log-rank P < 0.001). Accordingly, based on the optimal cut-off values of 24.0% for CS percentage change and 9.3% for RS percentage change, there were also significant differences in survival (log-rank P < 0.001) ( Figure 1E and F) .
Kaplan-Meier survival curves
Univariate Cox regression analysis
In univariate analysis, NYHA class, AF, and BNP levels were the only clinical predictors of mortality during follow-up (P < 0.001), while cardiomyopathy aetiology (ischaemic vs. non-ischaemic) was not related to mortality [HR 1.181, 95% confidence interval (CI) 0.590-2.365, P = 0.639] ( Table 2) . A greater LVOT-VTI at rest and a greater dobutamine-induced change in LVESV were associated with a lower risk for death (P = 0.044 and P = 0.047, respectively). Among the deformation echocardiographic measurements at rest, only increased values of RS and RSR were associated with survival (P < 0.001), while longitudinal and circumferential speckle tracking measurements were not. In contrast, dobutamine-induced changes of all speckle tracking indices were related to significant risk for cardiac mortality ( Table 2) . Among the traditional echocardiography markers at rest, DT of the mitral E wave, E/E', LA diameter, TAPSE, sPAP, and S' were related to significant risk for cardiac mortality (P < 0.05, 
Multivariate Cox regression analysis
By multivariate analysis, each of the echocardiography markers or its change by dobutamine was added separately into the basic model to avoid collinearity. Among all standard echocardiographic indices, none was related to outcome adjusting for the parameters of the basic model ( Table 2 ) except LA diameter (P = 0.018) and S' at rest (P = 0.007). Among measured markers of myocardial deformation at rest, only RS and RSR exhibited a statistically significant association with mortality (P = 0.001 and P = 0.021, respectively) after adjustment for the parameters of the basic model. In contrast, dobutamine-induced changes of all speckle tracking indices exerted a significant effect on mortality in multivariate analysis ( Table 2 ; see also Supplementary material online, Tables S1 and S2). There was no significant interaction between type of cardiomyopathy and speckle tracking markers in multivariate analysis.
Multivariate predictive models
Based on corrected Harrell's C-indices and bootstrapped net reclassification ( Table 2) , we showed that the basic model had a reasonable predictive value (corrected C-index = 0.732, 0.7 < C-index ≤0.8). Of all echo parameters, rest RS and GLS change post-DSE showed the greatest corrected C-index after inclusion separately in our basic model (corrected C-index = 0.818 and 0.821; and NRI = 0.257 and 0.393, respectively, Table 2 ) and thus were used in the final multivariate analysis. A GLS percentage increase post-LDSE >19.0% was also a significant predictor of cardiac death (corrected C-index = 0.775 and NRI = 0.307, P = 0.01, Table 2 ). To examine the additive predictive value of rest RS and GLS change post-DSE for mortality, we considered three predictive models by an additive stepwise algorithm: the basic model, the basic model plus RS at rest (additive model 1, or model 1), and the basic model plus RS at rest plus the dobutamine-induced GLS change (additive model 2, or model 2). Both additive models 1 and 2 differed significantly from the basic model as assessed by 2 test of log-likelihood ratios (P < 0.001). The same holds true for the comparison between model 1 and model 2 (−2log-likelihood = 235.8 and 217.32, respectively; P < 0.001). In model 1, both BNP and RS at rest maintained their statistical significance (P = 0.048 and P = 0.001, respectively), suggesting an additive value of RS at rest to BNP. Figure 2 shows the adjusted HRs of each variable in model 2. In this final model, both RS at rest and GLS change with LDSE were significant predictors of mortality (HR 0.474, 95% CI 0.229-0.976, P = 0.04; HR 2.054, 95% CI 1.415-2.981, P < 0.001 respectively). With regard to prediction ability, the final model including both RS at rest and GLS change post-DSE scored much higher compared with the basic model [corrected C-index = 0.825 vs. corrected C-index = 0.732, respectively, with NRI = 0.518 (95% CI 0.137-0.688), P = 0.022 against the basic model]. Figure S1 in the Supplementary material online shows the cumulative case/dynamic control ROC curves comparatively for the three models at different time points during follow-up. In this diagram, model 2 had a greater cumulative area under the curve (AUC) at all time points compared with the other two models. The same trends hold for the incident case/dynamic control ROC curves as plotted against time ( Figure 3) . As shown in Figure 3 , the average instantaneous concordance index of the final model is greater than that of the other two models at any time point during follow-up.
To avoid overfitting, we also performed a stepwise regression analysis which included age and sex as step 1 plus the variables with P < 0.05 at univariate analysis, i.e. BNP and NYHA, as step 2 plus baseline RS as step 3, and finally GLS change post-DSE as step 4. In the final model of six variables, baseline RS and GLS change post-DSE were independently associated with cardiac death (P < 0.05, Table 3 ). This final model including both RS rest and GLS change post-DSE scored much higher compared with the model of four variables Table 3 ]. We also examined the incremental prognostic role of rest RS and GLS change post-DSE over traditional 2D Doppler and tissue Doppler echocardiography parameters related to prognosis using a stepwise multivariable model ( Table 4 ). In this model, we included at the last step age, sex, rest RS, GLS change post-DSE, and each one of the traditional echocardiography variables separately: namely LA diameter, DT of mitral E wave, S', E/E' ratio, sPAP, and TAPSE (Table 4) , as well as LVOT-VTI and LVESV (Supplementary material online, Table S3 ). In all multivariable models, RS at rest and GLS change post-DSE demonstrated a significant incremental prognostic role to traditional echocardiographic parameters (P < 0.05).
We have also conducted a stepwise backward regression analysis starting from a multivariable model which included all examined clinical and echocardiography variables [namely, clinical variables: age, sex, rhythm, ischaemic aetiology, NYHA class, glomerular filtration rate, systolic BP (SBP) at rest and SBP change, diastolic BP (DBP) at rest and DBP change, heart rate at rest, and heart rate change; traditional echo variables: E/E', DT, S', TAPSE, LA diameter at rest, LVEDD at rest and change, LVESD at rest and change, LVEDV at rest and change, LVESV at rest and change, LVEF at rest and its increase by 5% with dobutamine, and LVOT-VTI at rest and increase by 20% with dobutamine; speckle tracking echo variables: GLS at rest and GLS change, CS at rest and CS change, RS at rest and RS change; strain rate parameters were examined separately from strain parameters because of collinearity]. Age and sex were forced to remain in the model during the iterations and all steps of the backward regression analysis. Backward elimination was based on likelihood ratio test and Wald test. With both tests, RS at rest and GLS change post-DSE remained significant independent predictors of cardiac mortality at the last step (P < 0. 
Association of myocardial deformation markers with death from pump failure or sudden death
In univariate analysis, both RS at rest and GLS change with LDSE were significant predictors of mortality from sudden death or pump failure (P < 0.05). In multivariate analysis, adjusting for the parameters of the basic model, RS at rest and GLS change with LDSE were both predictors of mortality from pump failure (HR 0.171, 95% CI 0.058-0.503, P = 0.001; and HR 1.324, 95% CI 1.010-1.840, P = 0.021, respectively) while GLS change with LDSE was the only predictor of sudden death (HR 6.915, 95% CI 2.959-16.16, P < 0.0010. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Harrell's C-index 1000-loops bootstrapped estimation for correction of overoptimism. c Category-free NRI estimation made with 1000-loops bootstrapping in order to improve overoptimism of the sample estimator. NRI is not applicable for the basic model. Harrell's C-index 1000-loops bootstrapped estimation for correction of overoptimism.
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c Category-free NRI estimation made with 1000-loops bootstrapping in order to improve overoptimism of the sample estimator. NRI is not applicable for the basic model.
Association of myocardial deformation markers with left ventricular ejection fraction change at follow-up
Fifty-eight out of the 68 survivors had a follow-up echocardiography study at 46 ± 2 months after inclusion in the study. By linear regression analysis, patients with rest RS >15.31% exhibited a relative increase in LVEF at follow-up of 9.7% (95% CI 3.8-15.7%) compared with patients with rest RS <15.31% who had a relative decrease in LVEF at follow-up of −2.3% (95% CI −7.1 to 2.5%) (P = 002). Patients with GLS change post-DSE >19% exhibited a relative increase in LVEF at follow-up of 13.7% (95% CI 8.8-18.7%) compared with patients with GLS change <19% who had a relative decrease in LVEF at follow-up of −2.1% (95% CI −5.5 to 1.2%); P < 0.001. There was a close association between GLS change post-DSE and GLS values at follow-up (beta regression coefficient = 0.70, P < 0.001). Patients with a GLS change post-LDSE >19% had higher GLS values at follow-up compared with those with GLS change <19% (−13.7 ± 4.8 vs. -8.6 ± 4.4%, P < 0.001).
Discussion
The present study shows that the dobutamine-induced change of myocardial deformation in all three-dimensional directions (longitudinal, circumferential, and radial) is associated with cardiac mortality in patients with severe HFrEF. However, dobutamine-induced change in longitudinal myocardial deformation is the best predictor to stratify the risk for cardiac death, particularly when combined with reduced radial deformation at rest.
In our study, we confirmed that in patients with severe HFrEF, all multidimensional deformation indices are impaired. This is in keeping with previous reports where it has been stated that, at the first stage of heart failure, long axis deformation is depressed whereas, as ventricular dysfunction progresses, the initially compensating mid-wall fibres alter their contraction, leading first to the deterioration of circumferential and then radial deformation. 9, 15 Interestingly, it has been reported that LV long-axis rather than short-axis function independently predicted survival in chronic heart failure.
15 Accordingly, and in keeping with previous reports, 15 we showed that, in patients with advanced HFrEF, decreased longitudinal 'mechanics' were associated with increased cardiac events regardless of the underlying disease; ischaemic or non-ischaemic cardiomyopathy. 16 -18 It has been proposed by previous studies that the excessive elevation of LV diastolic filling pressures may cause extravascular compression of the coronary micro-vessel and impaired coronary flow reserve leading to subendocardial ischaemia and thus to impairment of longitudinal deformation at rest and during stress in dilated cardiomyopathies.
19
In ischaemic cardiomyopathy, the longitudinally oriented subendocardial fibres are more susceptible to ischaemia and thus it might be expected that the longitudinal function is altered earlier than the mid-wall function, even though all deformation indices become depressed over time in patients with advanced heart failure. This may explain the fact that, in our study, a reduction in resting radial deformation accounted for increased mortality. Indeed, . . 20 Similarly, all deformational parameters are decreased in idiopathic dilated cardiomyopathy. 21 Thus, the myocardial fibres that contribute to deformation might be affected by the disease process in patients with dilated cardiomyopathy (ischaemic and non-ischaemic) and might alter the magnitude of cardiac mechanics. In a recent study, GLS at rest was shown to be an independent predictor of all-cause mortality in patients with HFrEF. 22 However, in this study there was no assessment of cardiac mortality, and the authors reported a significant interaction between GLS and AF and gender, implying a limitation in the predictive value of resting GLS. Thus, evaluation of the inotropic reserve of LV longitudinal deformation may provide greater predictive information for cardiac mortality than evaluation of LV deformation at rest as shown in our study. Taking all this into account, it seems that, regardless of aetiology of heart failure, LV myocardial deformation in the longitudinal direction is the first to be impaired in patients with preserved or reduced LVEF and subclinical systolic dysfunction, whereas all three multidimensional components of LV contraction are significantly impaired in patients with HFrEF as disease progresses.
18,23
In patients with severe LV dysfunction, parameters of LV systolic function such as LVEF derived by traditional echocardiography, particularly when determined at rest, might have poor prognostic significance. 2 Several studies showed that contractile reserve is well correlated with VO 2max , can evaluate the functional status of the heart, 3 and may also be used as a valuable prognostic indicator for adverse outcome. 4 However, other studies failed to reach the same conclusions. 24 These discrepancies in published studies may partly be explained by differences in the degree of histomorphometric changes in different stages of disease, and/or by the lack of multidimensional determination of contractile reserve. Indeed, it has recently been reported that, in patients with advanced HFrEF, the dobutamine-induced changes of GLS and GLSR, compared with conventional measurement of contractile reserve, were the best predictors of preserved functional capacity. 9 In the present study, the dobutamine-induced changes of GLS had the greatest AUC for the prediction of cardiac mortality compared with the remaining speckle tracking markers and markers of conventional echocardiography measured at rest or after LDSE. Thus, a dobutamine-induced change of GLS <19% was the best predictor of cardiac mortality during 4 years of follow-up. Furthermore, longitudinal deformation markers had an additive value to baseline BNP, contractile reserve, as assessed by changes of conventional echocardiography markers, and other clinical parameters for the prediction of cardiac mortality. This finding suggests the importance of longitudinal myocardial deformation in the determination of LV performance and, thus, prognosis in patients with HF.
However, in multivariate analysis, there was an additive value of RS at rest, such that a model including resting RS, BNP, and other traditional predictors of mortality had an NRI of 0.257, while the addition of the dobutamine-induced change of GLS in a second step increased the NRI to 0.518. Furthermore, the combination of rest RS and dobutamine-induced changes of GLS had an incremental prognostic role in cardiac mortality in multivariate models including LVEF, LVOT-VTI, LA diameter, DT of the mitral E wave, S', E/E' ratio, sPAP, and TAPSE. These findings suggest a profound disease progression affecting the circumferentially oriented, mid-endocardial myocardial fibres, which determine the radial deformation, in addition to the longitudinally oriented, subendocardial myocardial layers. Thus, a resting value of radial strain <15.3% when combined with dobutamine-induced change of GLS <19% characterizes the patients at highest risk for adverse outcome. Studies indicate that the radial strain reflects the sum of the deformation of all three myocardial layers: subepicardial, mid-myocardial, and subendocardial. 25 Thus, a reduced RS at rest reflects severe transmural myocardial damage. 26 The reduced GLS reflects impairment of longitudinal myocardial fibres. The increase of GLS after dobutamine indicates the lack of irreversible fibrosis and myocardial cell damage. An increase in GLS after dobutamine results in improved LV systolic emptying and consequently to reduced residual blood volume in the left ventricle at the beginning of early diastolic filling, increased restoring forces, and, thus, reduction of LV diastolic pressure, with consequent alleviation of subendocardial compression of the coronary microcirculation.
Limitations
In our study, the sample size was small and not representative of all aspects of heart failure as only eight and four patients had an implantable cardioverter defibrillator and CRT device, respectively. Furthermore, the majority of our patients were men (84%), a significant number of patients had ischaemic cardiomyopathy (44%), and the overall cohort size was modest, thus restricting the number of variables to be included in multivariate analysis. In our study, patients with extensive myocardial ischaemia requiring revascularization were excluded and thus there was an over-representation of non-ischaemic cardiomyopathy (56%), and follow-up data on survival of patients after revascularization were not available for analysis. Although all patients were on maximal tolerated medical treatment at baseline, monitoring of changes in medication during follow-up was not available in all patients. Thus, the findings of this study should not be generalized to all heart failure patients. The feasibility of measurement of myocardial deformation markers in patients with advanced heart failure is >95% at rest and 93% at LDSE in our laboratory. Interpretation of RS and CS may be complicated by the presence of substantial transmural non-uniformity in the left ventricle. Thus, our results should be interpreted taking these limitations into account. Because of our exclusion criteria, the results of this study cannot be applied to patients with severe mitral regurgitation. We have to acknowledge that there is intervendor variability and lack of standardization of speckle tracking analysis. Finally, we have not recorded data on the changes of the patients' functional capacity in association with the response to LDSE during follow-up.
Conclusions
In patients with severe HFrEF, the lack of response of myocardial deformation markers to dobutamine is related to cardiac death after adjustment for traditional clinical and echocardiography parameters including BNP. Radial strain appears to be the best . predictor of adverse outcome among all other echocardiographic parameters at rest. LDSE offers a useful prognostic tool in HFrEF, because the dobutamine-induced change in GLS is the strongest predictor of long-term cardiac mortality with an additive prognostic value to LV RS at rest in our study. Thus, the response of myocardial deformation markers during LDSE may be used for a better risk stratification of patients with advanced heart failure and treatment could be tailored in these patients. In patients with lack of an adequate response of myocardial deformation to LDSE, the need for intense medical follow-up and utilization of invasive strategies such as LV assist devices and cardiac transplantation when appropriate may be needed to alter the prognosis.
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